Wird geladen...
Revisiting 5α-reductase inhibitors and the risk of prostate cancer
The role of 5α-reductase inhibitors (5-ARI) in prostate cancer chemoprevention remains a controversy, as cancer prevention trials with 5-ARIs have shown a decreased incidence of low-grade prostate cancer but a potential increased risk in high-grade disease. Recent studies have shed light on the long...
Gespeichert in:
| Veröffentlicht in: | Nat Rev Urol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6358277/ https://ncbi.nlm.nih.gov/pubmed/29740116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41585-018-0018-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|